Legal Requirements for the Quality of Herbal Substances and Herbal Preparations for the Manufacturing of Herbal Medicinal Products in the European Union[*]

Abstract

In the European Union (EU) herbal medicinal products have become increasingly important. This is, for instance, underlined by the recent introduction of a simplified procedure in the Member States of the EU allowing the registration of herbal medicinal products which fulfill the criteria of a traditional herbal medicinal product, i.e., sufficient evidence of its medicinal use throughout a period of at least 30 years for products in the EU and at least 15 years within the EU and 15 years elsewhere for products outside the EU. With regard to the manufacturing of these products and their quality, applications of traditional herbal medicinal products have to fulfil the same requirements as applications for a marketing authorization. The quality of herbal substances as well as herbal preparations will be determined by the availabilty of modern science-based public monographs in the European Pharmacopoeia and their equivalents developed by the pharmaceutical industry. The standards put forward in these monographs must allow us not only to define the quality of these products, but also to eliminate dangerous counterfeit, substandard, adulterated and contaminated (traditional) herbal medicinal products. The usefulness of these monographs to implement the criteria on quality and specifications put forward for these products in the different guidelines of the European Medicines Agency (EMEA) is discussed.

Key words

herbal substance - herbal preparation - herbal medicinal product - quality - European Pharmacopoeia - European Medicines Agency - Committee on Herbal Medicinal Products

1 History: This article is based on a plenary lecture, presented by A. J. Vlietinck, as recipient of the Phytochemical Society of Europe Silver Medal at the 7th Joint Meeting of AFERP, ASP, GA, PSA and SIF in Athens on August 4, 2008.

References

• 1 European Union Law website. Available at: http://eur-lex.europa.eu/en/index.htm. Accessed September 5, 2008. 
• 2 Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to medicinal products for human use. Official Journal of the European Union: L311/67. 28.November.2001: 67-128
• 3 Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community Code relating to medicinal products for human use. Official Journal of the European Union: L136/34. 30.April.2004: 34-57
• 4 Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community Code relating to medicinal products for human use. Official Journal of the European Union: L183/51. 30.April.2004: 85-90
• 5 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Union: L183. 12.July.2002: 51-57
• 6 Council Regulation (EC) No 1924/2006 of the European Parliament and the Council of 20th December 2006 on nutrition and health claims made on foods. Official Journal of the European Union: L404/9. 30.December.2006: 9-25
• 7 Council Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20th December 2006 on the addition of vitamins and minerals and of certain other substances to foods. Official Journal of the European Union: L404/26. 30.December.2006: 2638
• 8 Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients. Official Journal of the European Union: L043/1. 14.February.1997: 1-6
• 9 Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States, relating to cosmetic products. Official Journal of the European Union: L262. 27.September.1976: 169-200
• 10 Council Regulation 2309/93 EEC of the European Parliament and of the Council of 22 July 1993. Laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European agency for the evaluation of medicinal products. Official Journal of the European Union: L214. 24.August.1993: 1-31
• 11 Benzi G, Ceci A. Herbal medicines in European regulation.  Pharmacol Res. 1997;  35 355-362
• 12 Steinhoff B, Sagel A, Küpper S D. Herbal medicinal products in Germany: scientific knowledge and regulatory framework. 2nd English edition. Bonn; Bundesverband der Arzneimittel-Hersteller e.V. 2008: 1-37
• 13 EMEA Committee on Herbal Medicinal Products (CHMP) .Guideline on non-clinical documentation for herbal medicinal products in applications for marketing authorization (bibliographic and mixed applications) and in applications for simplified registration. EMEA/HMPC/32116, 13 July 2006. Available at http://www.emea.europa.eu/htms/human/humanguidelines/nonclinical.htm. Accessed September.5.2008
• 14 EMEA Committee on Herbal Medicinal Products (CHMP) .Guideline on the assessment of clinical safety and efficacy in the preparation of monographs for well-established and of monographs/lists for traditional herbal medicinal products/substances/preparations, EMEA/HMPC/104613/2005, 7 September 2006. Available at http://www.emea.europa.eu/htms/human/humanguidelines/efficacy.htm. Accessed September.6.2008
• 15 Silano M, De Vincenzi M, De Vincenzi A, Silano V. Commentary: the new European legislation on traditional herbal medicines: main features and perspectives.  Fitoterapia. 2004;  75 107-116
• 16 EMEA Committee on Herbal Medicinal Products (CHMP) and Committee on Medicinal Products for Veterinary Use (CVMP) .Guideline on quality of herbal medicinal products/traditional herbal medicinal products, CPMP/QWP/2819/00 Rev 1 or EMEA/CVMP/814/00 Rev 1, 30 March 2006. Available at http://www.emea.europa.eu/htms/human/humanguidelines/quality.htm. Accessed September.6.2008
• 17 EMEA Committee on Herbal Medicinal Products (CHMP) and Committee on Medicinal Products for Veterinary Use (CVMP) .Guideline on Specifications: Test Procedures and Acceptance Criteria for Herbal Preparations and Herbal Medicinal Products/Traditional Herbal Medicinal Products, CPMP/QWP/2820/00 Rev 1 or EMEA/CVMP/815/00 Rev 1, 30 March 2006. Available at http://www.emea.europa.eu/htms/human/humanguidelines/quality.htm. Accessed September.6.2008
• 18 Bauer R. Quality criteria and standardization of phytopharmaceuticals: can acceptable drug standards be achieved?.  Drug Inform J. 1998;  32 101-110
• 19 Busse W. The significance of quality for efficacy and safety of herbal medicinal products.  Drug Inform J. 2000;  34 15-23
• 20 European Directorate for the Quality of Medicines & Health Care .European pharmacopoeia. Available at http://online.edqm.eu/entry.htm. Accessed September.8.2008
• 21 Artiges A. The role of pharmacopoeias in international harmonisation.  J Pharm Biomed Anal. 2001;  24 769-772
• 22 Gaedcke F, Steinhoff B. Herbal medicinal products. Stuttgart; Medpharm Scientific Publishers, CRC Press 2003: 37-65
• 23 [no authors listed]. European Pharmacopoeia. 6th edition, Vol. 6.1. Strasbourg; Council of Europe 2007: 3343-3344
• 24 Chandron S, Singh R SP. Comparison of various international guidelines for analytical method validation.  Pharmazie. 2007;  62 1-14

1 History: This article is based on a plenary lecture, presented by A. J. Vlietinck, as recipient of the Phytochemical Society of Europe Silver Medal at the 7th Joint Meeting of AFERP, ASP, GA, PSA and SIF in Athens on August 4, 2008.